ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin, SGLT2 Inhibitor or Both

ClinicalTrials.gov ID: NCT06534411

Public ClinicalTrials.gov record NCT06534411. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 8, 2026, 3:56 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Efficacy and Safety of Co-administered Cagrilintide and Semaglutide (CagriSema) 1.0 mg/1.0 mg s.c. Once Weekly Versus Tirzepatide 5 mg s.c. Once Weekly in Participants With Type 2 Diabetes Inadequately Controlled on Metformin, SGLT2 Inhibitor or Both

Study identification

NCT ID
NCT06534411
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novo Nordisk A/S
Industry
Enrollment
1,023 participants

Conditions and interventions

Interventions

  • Cagrilintide Drug
  • Semaglutide Drug
  • Tirzepatide Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 4, 2024
Primary completion
Jun 1, 2026
Completion
Jul 13, 2026
Last update posted
May 4, 2026

2024 – 2026

United States locations

U.S. sites
54
U.S. states
27
U.S. cities
50
Facility City State ZIP Site status
Cahaba Research Pelham Alabama 35124
Velocity Clinical Research-Phoenix Phoenix Arizona 85006
AES Tucson DRS Tucson Arizona 85712
Woodland Int. Research Group Little Rock Arkansas 72211
Velocity Clin Res-Chula Vista Chula Vista California 91911
John Muir Physicians Network Concord California 94520
Diabetes & Endocrine Specialists - La Mesa La Mesa California 91942
Velocity Clin Research LA Los Angeles California 90017
Desert Oasis Healthcare Palm Springs California 92262
Velocity Clin Res Santa Ana Santa Ana California 92704
Velocity Clin Res - Panorama Van Nuys California 91405
Optumcare Clinical Trials,LLC-Golden Colorado Springs Colorado 80906
FEME Medical LLC Washington D.C. District of Columbia 20010
Tampa Bay Medical Research Clearwater Florida 33761
AGA Clinical Trial Hialeah Florida 33012
Bioclinical Research Alliance Miami Florida 33155
New Horizon Research Center Miami Florida 33165
South Broward Research LLC Miramar Florida 33027
West Orange Endocrinology Ocoee Florida 34761
Optimal Research Sites Orange City Florida 32763
Center for Diab,Obes & Metab Pembroke Pines Florida 33024
Javara Inc. / Privia Medical Group Georgia LLC Fayetteville Georgia 30214
Clinical Invest Special_Gurnee Gurnee Illinois 60031
Iowa Diabetes & Endo Res Ctr West Des Moines Iowa 50266
Cotton-Oneill Diabetes and End Topeka Kansas 66606-2806
AES Minneapolis DRS Richfield Minnesota 55423
Velocity Clin Res Gulfport Gulfport Mississippi 39503
AES St. Louis DRS St Louis Missouri 63141
Univ of Nebraska Medical CTR Omaha Nebraska 68198-3020
Velocity Clin Res Albuquerque Albuquerque New Mexico 87107
Albany Medical College Albany New York 12203
Carteret Medical Group Morehead City North Carolina 28557
Piedmont Healthcare/Research Statesville North Carolina 28625
Lillestol Research LLC Fargo North Dakota 58104
Triad Research Institute Norman Oklahoma 73072
Circuit Clinical - PMSI Pottstown Pennsylvania 19464
Clinical Res Collaborative Cumberland Rhode Island 02864
Velocity Clin Res Providence East Greenwich Rhode Island 02818
Velocity Clin Res Gaffney Gaffney South Carolina 29340
Holston Medical Group Kingsport Tennessee 37660
Clinical Research Associates Nashville Tennessee 37203
Velocity Clin Res Austin Austin Texas 78759
AES Dallas DFW DRS Dallas Texas 75234
UT Southwestern Medical Center - Lingvay Dallas Texas 75390
JCCT- Juno NW Houston Houston Texas 77040
Discovery MM Services - Houston - Broadway Street Houston Texas 77061
PlanIt Research, PLLC Houston Texas 77079
Sante Clinical Research Kerrville Texas 78028
Aeres Clinical Research Laredo Texas 78041
RGV Endocrine Center McAllen Texas 78503
Privia Health Javara Clin Res. Stephenville Texas 76401
J.Lewis Research Inc Salt Lake City Utah 84109
Chrysalis Clinical Research St. George Utah 84790
TPMG Clinical Research Newport News Virginia 23606

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 109 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06534411, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 4, 2026 · Synced May 8, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06534411 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →